Literature DB >> 19034736

Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration.

Adam J Gordon1, Joseph Liberto, Stephanie Granda, Sara Salmon-Cox, Tykia Andree, Laura McNicholas.   

Abstract

Despite the high numbers of veterans with opioid dependence, few receive pharmacologic treatment for this disorder. The adoption of buprenorphine treatment within the Veterans Health Administration (VHA) has been slow. To expand capacity for buprenorphine treatment, the VHA sponsored two eight-hour credentialing courses for the Drug Addiction Treatment Act of 2000. We sought to describe the outcomes of such training. Following the training sessions, 29 participants (18 physicians) were highly satisfied with course content and affirmed their intention to prescribe buprenorphine; after nine-month follow-up, two physicians were prescribing. We conclude that providing credentialing courses, while popular, did not markedly promote the prescription of buprenorphine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034736     DOI: 10.1080/10550490802408613

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  13 in total

Review 1.  Update in addiction medicine for the generalist.

Authors:  Adam J Gordon; Hillary V Kunins; Darius A Rastegar; Jeanette M Tetrault; Alexander Y Walley
Journal:  J Gen Intern Med       Date:  2010-08-10       Impact factor: 5.128

2.  Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process.

Authors:  Carrie M Farmer; Dawn Lindsay; Jessica Williams; Amanda Ayers; James Schuster; Alyssa Cilia; Michael T Flaherty; Todd Mandell; Adam J Gordon; Bradley D Stein
Journal:  Subst Abus       Date:  2015-04-06       Impact factor: 3.716

3.  Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care.

Authors:  Evelyn T Chang; Rebecca S Oberman; Amy N Cohen; Stephanie L Taylor; Elisa Gumm; Aram S Mardian; Shawn Toy; Araceli Revote; Britney Lewkowitz; Elizabeth M Yano
Journal:  J Gen Intern Med       Date:  2020-11-03       Impact factor: 5.128

4.  Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps.

Authors:  Jessica J Wyse; Adam J Gordon; Steven K Dobscha; Benjamin J Morasco; Elizabeth Tiffany; Karen Drexler; Friedhelm Sandbrink; Travis I Lovejoy
Journal:  Subst Abus       Date:  2018       Impact factor: 3.716

5.  Brief Training on Medication-Assisted Treatment Improves Community Mental Health Clinicians' Confidence and Readiness to Address Substance Use Disorders.

Authors:  Theddeus Iheanacho; Tanner Bommersbach; Brian Fuehrlein; Bachaar Arnaout; Charles Dike
Journal:  Community Ment Health J       Date:  2020-02-15

6.  Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.

Authors:  Bradley D Stein; Rosalie Liccardo Pacula; Adam J Gordon; Rachel M Burns; Douglas L Leslie; Mark J Sorbero; Sebastian Bauhoff; Todd W Mandell; Andrew W Dick
Journal:  Milbank Q       Date:  2015-09       Impact factor: 4.911

7.  Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.

Authors:  Andrew W Dick; Rosalie L Pacula; Adam J Gordon; Mark Sorbero; Rachel M Burns; Douglas Leslie; Bradley D Stein
Journal:  Health Aff (Millwood)       Date:  2015-06       Impact factor: 6.301

Review 8.  Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.

Authors:  Elizabeth M Oliva; Natalya C Maisel; Adam J Gordon; Alex H S Harris
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

Review 9.  Buprenorphine Prescribing: To Expand or Not to Expand.

Authors:  Xiaofan Li; Daryl Shorter; Thomas R Kosten
Journal:  J Psychiatr Pract       Date:  2016-05       Impact factor: 1.325

10.  Supply of buprenorphine waivered physicians: the influence of state policies.

Authors:  Bradley D Stein; Adam J Gordon; Andrew W Dick; Rachel M Burns; Rosalie Liccardo Pacula; Carrie M Farmer; Douglas L Leslie; Mark Sorbero
Journal:  J Subst Abuse Treat       Date:  2014-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.